SLRX icon

Salarius Pharmaceuticals

11 hedge funds and large institutions have $104K invested in Salarius Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
11
Holders Change
+5
Holders Change %
+83.33%
% of All Funds
0.15%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
2
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
HF
1
HRT Financial
New York
$28K +$28K +2,112 New
UBS Group
2
UBS Group
Switzerland
$16.3K -$14K -1,045 -46%
CSS
3
Cubist Systematic Strategies
Connecticut
$15K +$15K +1,115 New
Goldman Sachs
4
Goldman Sachs
New York
$14.9K +$14.9K +1,111 New
Geode Capital Management
5
Geode Capital Management
Massachusetts
$13.9K +$3.63K +270 +35%
Barclays
6
Barclays
United Kingdom
$7K +$7K +535 New
Citigroup
7
Citigroup
New York
$5.28K +$5.28K +393 New
TRCT
8
Tower Research Capital (TRC)
New York
$3.28K +$296 +22 +10%
Osaic Holdings
9
Osaic Holdings
Arizona
$297
MYIA
10
Mount Yale Investment Advisors
Colorado
$55 +$55 +4 New
Bank of America
11
Bank of America
North Carolina
$16
Morgan Stanley
12
Morgan Stanley
New York
$6 -$5
BlackRock
13
BlackRock
New York
$1 -$1
SS
14
SBI Securities
Japan
$1 -$1
TSS
15
Two Sigma Securities
New York
-$11.6K -1,023 Closed